Biomaterial Database

[Pregnancy in a subject with prolactin-secreting pituitary adenoma during therapy with bromocriptine]. 1980

G Passannanti, and A Cardone, and F Marafioti, and N Alvino

UI	MeSH Term	Description	Entries
D010911	Pituitary Neoplasms	Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.	Pituitary Cancer,Cancer of Pituitary,Cancer of the Pituitary,Pituitary Adenoma,Pituitary Carcinoma,Pituitary Tumors,Adenoma, Pituitary,Adenomas, Pituitary,Cancer, Pituitary,Cancers, Pituitary,Carcinoma, Pituitary,Carcinomas, Pituitary,Neoplasm, Pituitary,Neoplasms, Pituitary,Pituitary Adenomas,Pituitary Cancers,Pituitary Carcinomas,Pituitary Neoplasm,Pituitary Tumor,Tumor, Pituitary,Tumors, Pituitary
D011247	Pregnancy	The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.	Gestation,Pregnancies
D011252	Pregnancy Complications, Neoplastic	The co-occurrence of pregnancy and NEOPLASMS. The neoplastic disease may precede or follow FERTILIZATION.	Complications, Neoplastic Pregnancy,Neoplastic Pregnancy Complications,Pregnancy, Neoplastic Complications,Complication, Neoplastic Pregnancy,Neoplastic Pregnancy Complication,Pregnancies, Neoplastic Complications,Pregnancy Complication, Neoplastic
D011388	Prolactin	A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate.	Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D001971	Bromocriptine	A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion.	2-Bromoergocryptine,Bromocryptin,2-Bromo-alpha-ergocryptine,2-Bromo-alpha-ergokryptine,2-Bromoergocryptine Mesylate,2-Bromoergocryptine Methanesulfonate,2-Bromoergokryptine,Bromocriptin,Bromocriptine Mesylate,CB-154,Parlodel,2 Bromo alpha ergocryptine,2 Bromo alpha ergokryptine,2 Bromoergocryptine,2 Bromoergocryptine Mesylate,2 Bromoergocryptine Methanesulfonate,2 Bromoergokryptine,CB 154,CB154,Mesylate, 2-Bromoergocryptine,Mesylate, Bromocriptine,Methanesulfonate, 2-Bromoergocryptine
D005260	Female		Females
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000236	Adenoma	A benign epithelial tumor with a glandular organization.	Adenoma, Basal Cell,Adenoma, Follicular,Adenoma, Microcystic,Adenoma, Monomorphic,Adenoma, Papillary,Adenoma, Trabecular,Adenomas,Adenomas, Basal Cell,Adenomas, Follicular,Adenomas, Microcystic,Adenomas, Monomorphic,Adenomas, Papillary,Adenomas, Trabecular,Basal Cell Adenoma,Basal Cell Adenomas,Follicular Adenoma,Follicular Adenomas,Microcystic Adenoma,Microcystic Adenomas,Monomorphic Adenoma,Monomorphic Adenomas,Papillary Adenoma,Papillary Adenomas,Trabecular Adenoma,Trabecular Adenomas
D000328	Adult	A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.	Adults

Related Publications

G Passannanti, and A Cardone, and F Marafioti, and N Alvino

Bromocriptine therapy for prolactin-secreting pituitary adenomas.

July 1996, Neurosurgical focus,

G Passannanti, and A Cardone, and F Marafioti, and N Alvino

Conservative management of suspected prolactin secreting pituitary adenoma during pregnancy.

April 1981, European journal of obstetrics, gynecology, and reproductive biology,

G Passannanti, and A Cardone, and F Marafioti, and N Alvino

Interactions between thioridazine and bromocriptine in a patient with a prolactin-secreting pituitary adenoma.

May 1984, The American journal of medicine,

G Passannanti, and A Cardone, and F Marafioti, and N Alvino

Complete Shrinking of Mixed Growth Hormone and Prolactin-Secreting Pituitary Adenoma With Bromocriptine Therapy Alone.

May 2024, The Journal of craniofacial surgery,

G Passannanti, and A Cardone, and F Marafioti, and N Alvino

Thyrotropin-secreting pituitary adenoma responsive to bromocriptine therapy.

January 1999, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,

G Passannanti, and A Cardone, and F Marafioti, and N Alvino

Effects of preoperative bromocriptine treatment on prolactin-secreting pituitary adenoma surgery.

May 2016, Experimental and therapeutic medicine,

G Passannanti, and A Cardone, and F Marafioti, and N Alvino

Prolactin-secreting pituitary adenoma.

October 1982, The Medical journal of Australia,

G Passannanti, and A Cardone, and F Marafioti, and N Alvino

Enlargement of a prolactin-secreting pituitary microadenoma during bromocriptine treatment.

July 1982, British journal of obstetrics and gynaecology,

G Passannanti, and A Cardone, and F Marafioti, and N Alvino

Effects of bromocriptine-induced pregnancy on prolactin-secreting pituitary tumours.

November 1981, Acta endocrinologica,